Published online before print August 21, 2003, doi: 10.1161/01.RES.0000092142.19896.D9
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 3, 2003
Revised on August 12, 2003
Accepted on August 12, 2003
Plasma Membrane Calcium ATPase Overexpression in Arterial Smooth Muscle Increases Vasomotor Responsiveness and Blood Pressure
Robert Gros ;
From the Heart & Stroke Richard Lewar Center of Excellence, Department of Medicine, University of Toronto, and Toronto General Hospital Research Institute, Toronto, Ontario, Canada.
* To whom correspondence should be addressed. E-mail: mansoor.husain{at}utoronto.ca.
In vascular smooth muscle cells (SMCs), several mechanisms act in concert to regulate the intracellular calcium concentration [Ca2+]i, which may in turn affect vascular tone. One such mechanism is the extrusion of Ca2+ by the plasma membrane calcium ATPase (PMCA). To address, in particular, the role of the neuronal nitric oxide synthase (nNOS)-associating isoform PMCA4b in regulating vascular tone, a doxycycline-responsive transgene for human PMCA4b was overexpressed in arterial SMCs of mice. Overexpression of hPMCA4b resulted in a 2-fold increase in total aortic PMCA4 protein expression and significant real-time RT-PCR-documented differences in the levels of endogenous mouse PMCA1, PMCA4, SERCA2, and IP3R1 gene expression in arterial SMCs. Whereas no significant difference in basal [Ca2+]i or Ca2+ sensitivity was observed in vascular SMCs or mesenteric arteries, respectively, from hPMCA4b-overexpressing versus control mice, hPMCA4b-overexpressing mice revealed a reduced set-point and increased extent of myogenic response and heightened sensitivity to vasoconstrictors. Treatment of arteries with an nNOS inhibitor resulted in a reduced set-point and increased extent of the myogenic response in control but not hPMCA4b-overexpressing mice. Moreover, aortic SMCs from hPMCA4b-overexpressing mice exhibited reduced levels of cGMP under both basal and phenylephrine-stimulated conditions. These changes were associated with significant doxycycline-reversible elevations in blood pressure. Taken together, these data show that overexpression of hPMCA4b in arterial SMCs increases vascular reactivity and blood pressure, an effect that may be mediated in part by negative regulation of nNOS.
Key words: transgenic mice • blood pressure • nitric oxide synthase • intracellular calcium • myogenic tone
This article has been cited by other articles:
 |
|
 |
|
  M. Brini and E. Carafoli Calcium Pumps in Health and Disease Physiol Rev, October 1, 2009; 89(4): 1341 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Oceandy, E. J. Cartwright, M. Emerson, S. Prehar, F. M. Baudoin, M. Zi, N. Alatwi, L. Venetucci, K. Schuh, J. C. Williams, et al. Neuronal Nitric Oxide Synthase Signaling in the Heart Is Regulated by the Sarcolemmal Calcium Pump 4b Circulation, January 30, 2007; 115(4): 483 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pande, K. K. Mallhi, A. Sawh, M. M. Szewczyk, F. Simpson, and A. K. Grover Aortic smooth muscle and endothelial plasma membrane Ca2+ pump isoforms are inhibited differently by the extracellular inhibitor caloxin 1b1 Am J Physiol Cell Physiol, May 1, 2006; 290(5): C1341 - C1349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lee, R. Agah, M. Xiao, A. D. Frutkin, M. Kremen, H. Shi, and D. A. Dichek Regulated Transgene Expression in Vascular Smooth Muscle Circ. Res., October 14, 2005; 97(8): e85 - e85. [Full Text] [PDF]
|
|
|
|
|
|
S. Handa, M. A. Momen, A.-M. Sadi, T. Afroze, C. Wang, and M. Husain Troubles With a Transgene: Experiences With SM22{alpha}-tTA Mice Circ. Res., October 14, 2005; 97(8): e85 - e87. [Full Text] [PDF]
|
|
|
|
|
|
M. Toporsian, R. Gros, M. G. Kabir, S. Vera, K. Govindaraju, D. H. Eidelman, M. Husain, and M. Letarte A Role for Endoglin in Coupling eNOS Activity and Regulating Vascular Tone Revealed in Hereditary Hemorrhagic Telangiectasia Circ. Res., April 1, 2005; 96(6): 684 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Fleming Brain in the Brawn: The Neuronal Nitric Oxide Synthase as a Regulator of Myogenic Tone Circ. Res., October 3, 2003; 93(7): 586 - 588. [Full Text] [PDF]
|
|